(Q36452552)

14 August 2017

1 reference

title

New pharmacologic approaches to the prevention of space/motion sickness (English)

1 reference

14 August 2017

New Pharmacologic Approaches to the Prevention of Space/Motion Sickness (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

23 October 2022

author name string

R. L. Kohl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662231

23 October 2022

S. MacDonald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662231

23 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1662231

23 October 2022

publication date

1 October 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1991.tb03653.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1991.tb03653.x/fullpdf

23 October 2022

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

The Journal of Clinical Pharmacology

23 October 2022

published in

1 reference

14 August 2017

volume

31

1 reference

14 August 2017

issue

10

1 reference

14 August 2017

page(s)

934-946

1 reference

Antimotion Sickness and Antiemetic Drugs

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Motion sickness: A modulatory role for the central cholinergic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Diuretic action of the narcotic antagonist oxilorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Opioid modulation of vasopressin secretion in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Arginine vasopressin--a mediator of chemotherapy induced emesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Differential release of vasopressin and oxytocin in response to abdominal vagal afferent stimulation or apomorphine in the ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Fluorescence histochemical and microspectrofluorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a κ-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Displacement of 3H-EKC binding by opioids in rat kidney: a correlate to diuretic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

beta-Endorphin secretion of arginine vasopressin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Colocalization of alpha-neo-endorphin and dynorphin immunoreactivity in hypothalamic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Opioid biology: the next set of questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Dynorphin 1-8 binds to opiate kappa receptors in the neurohypophysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Functional kappa-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Gastric relaxation and vomiting by apomorphine, morphine and fentanyl in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Endogenous opioid peptides: multiple agonists and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Enkephalin receptors in the emetic chemoreceptor trigger zone of the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Motion sickness reflex arc bypasses the area postrema in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Emetic and antiemetic effects of opioids in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

The physiology and pharmacology of emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Dexamethasone alters plasma levels of beta-endorphin and postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Which potent opioid? Important criteria for selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

3H-SKF10047 receptor binding studies. Attempts to define the opioid sigma receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1991.TB03653.X

Space motion sickness: phenomenology, countermeasures, and mechanisms

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Enhancement of human performance by caffeine and the amphetamines

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Spatial orientation in weightlessness and readaptation to earth's gravity

23 October 2022

11

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy

23 October 2022

12

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Diagnostic criteria for grading the severity of acute motion sickness

23 October 2022

13

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man

23 October 2022

19

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro

23 October 2022

21

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Mode of action of antidepressant drugs

23 October 2022

24

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Multiple-dose doxepin kinetics in depressed patients

23 October 2022

27

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight

23 October 2022

29

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Dexamethasone mimicks the antimotion sickness effects of amphetamine and scopolamine

23 October 2022

32

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Endocrine correlates of susceptibility to motion sickness

23 October 2022

35

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Meptazinol and Pentazocine: Effects on Prolactin, Growth Hormone and Vasopressin Levels in Plasma

23 October 2022

42

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Intravenous vasopressin in patients with portal hypertension: Advantages of continuous infusion

23 October 2022

45

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Pressor effect of arginine vasopressin in progressive autonomic failure

23 October 2022

46

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Influence of the emetic reflex on vasopressin release in man

23 October 2022

47

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha

23 October 2022

51

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Effect of +Gz and +Gx acceleration on peripheral venous ADH levels in humans

23 October 2022

52

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Plasma vasopressin and renin activity in women exposed to bed rest and +Gz acceleration

23 October 2022

53

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness

23 October 2022

55

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus

23 October 2022

56

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Motion sickness in the squirrel monkey

23 October 2022

59

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Vasopressin antagonism in the squirrel monkey (Saimiri sciureus)

23 October 2022

61

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans

23 October 2022

66

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Simultaneous monoamine histofluorescence and neuropeptide immunocytochemistry: II. Correlative distribution of catecholamine varicosities and magnocellular neurosecretory neurons in the rat supraoptic and paraventricular nuclei

23 October 2022

74

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Role of Endogenous Opioids in Neurohypophysial Function of Man*

23 October 2022

77

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

κ-opiates and urination: Pharmacological evidence for an endogenous role of the κ-opiate receptor in fluid and electrolyte balance

23 October 2022

80

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Physiology and pharmacology of vomiting

23 October 2022

94

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

23 October 2022

Space motion sickness

97

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Susceptibility to motion sickness and chemotherapy-induced side-effects

23 October 2022

98

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy

23 October 2022

99

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

The vomiting center; a critical experimental analysis

23 October 2022

101

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Immunohistochemical distribution of enkephalin neurons

23 October 2022

107

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Effect of ablation of area postrema on frequency and latency of motion sickness-induced emesis in the squirrel monkey

23 October 2022

111

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Motion-induced sickness following bilateral ablation of area postrema in squirrel monkeys

23 October 2022

112

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Experimental motion sickness in dogs; functional importance of chemoceptive emetic trigger zone

23 October 2022

113

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Regulation of nausea and vomiting in cancer chemotherapy. A review with emphasis on opiate mediators

23 October 2022

116

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Systemic naloxone increases the incidence of motion sickness in the cat

23 October 2022

117

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Naloxone enhances motion sickness: endorphins implicated

23 October 2022

120

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

Multiple opioid receptors

23 October 2022

122

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1991.TB03653.X

23 October 2022

Identifiers

1 reference

14 August 2017

1 reference